Zena Chen

Zena Chen

Auto-generated profile, based on publicly available information

Zena Chen

Department of Rheumatology and Immunology The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
ZCZena Chen
Zena Chen
XZXuqi Zheng
Xuqi Zheng
XWXinyu Wu
Xinyu Wu
JWJialing Wu
Jialing Wu
XLXiaomin Li
Xiaomin Li
JGJieruo Gu
Jieruo Gu
Growing evidence suggests that the gut microbiota is involved in the initiation and progression of ankylosing spondylitis (AS). In this study, we aimed to explore the gut microbiome alterations during adalimumab therapy and verify microbiome biomarkers predicting treatment response. By evaluating the gut microbial features of 30 AS patients before and after adalimumab therapy for 6 months and 24 healthy controls, we confirmed that the microbiome was restored remarkably after 6 months of adalimumab therapy in AS patients. We then compared the baseline gut microbiome of 22 adalimumab responders with 8 non-responders, a higher abundance of Comamonas was revealed in the latter, although no statistical difference was found after adjusting for the false discovery rate. These results suggested that adalimumab therapy restored the gut microbiome in AS patients and indicated the utility of gut microbiome to be potential biomarkers for therapeutic evaluation. These findings provided an insight into the development of predictive tools and the establishment of precise medical interventions for clinical practice.

15 November 2023 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
XZXuqi Zheng
Xuqi Zheng
ZCZena Chen
Zena Chen
XWXinyu Wu
Xinyu Wu
YXYa Xie
Ya Xie
JWJialing Wu
Jialing Wu
JGJieruo Gu
Jieruo Gu